Abstract
Objectives
Color Doppler ultrasound (CDUS) of the temporal arteries (TA) is becoming the first test to be performed for suspected giant cell arteritis (GCA). Our aim was to assess the added value of including CDUS of large vessels (LV) in the diagnosis of GCA.
Methods
We performed an observational and retrospective study of consecutive patients with suspected GCA. Baseline CDUS of the TA and LV (axillary, subclavian, and carotid) were conducted. We defined the CDUS finding as positive if the halo sign was present.
Results
Of 198 patients with suspected GCA, 87 were eventually diagnosed with GCA: 45 (51.7%) had a cranial pattern exclusively, 31 (35.6%) had both a cranial and an LV pattern, and 11 (12.6%) had an isolated LV pattern. CDUS of the TA had a sensitivity of 83.9%, specificity of 97.3%, and positive and negative predictive values (PPV, NPV) of 96.1% and 88.5%, respectively. When LV was added, sensitivity increased to 96.6% and NPV to 98.2%. Specificity was 97.3% and PPV was 96.6%. As for LVs, the axillary, subclavian, and carotid arteries were involved in 87.8%, 77.4%, and 34.4%, respectively. Isolated axillary examination resulted in a loss of 12.2% of patients with LV involvement; however, inclusion of the axillary and subclavian arteries retained 100% of patients with LV involvement.
Conclusions
Detection of GCA by ultrasound should routinely include examinations of the TA and LV (at least the axillary and subclavian arteries) to improve diagnostic accuracy. More than 12% of patients in our cohort had isolated LV involvement.
Key Points • Extracranial involvement in GCA is very common: half of patients have extracranial vasculitis and more than 12% isolated LV involvement that can be demonstrated with CDUS. • Adding a CDUS examination of LV to TA increased sensitivity (from 83.9 to 96.6%) and the negative predictive value (from 88.5 to 98.2%) for diagnosis of GCA. • In our cohort, if we only examined the axillary arteries, 12.2% of the CGA with LV involvement would not have been diagnosed. • We propose a CDUS protocol that includes examination of the TA and LV (at least the axillary and subclavian arteries) routinely in cases of suspected GCA. |
Similar content being viewed by others
References
Dumont A, Parienti J-J, Delmas C, Boutemy J, Maigné G, Martin Silva N et al (2020) Factors associated with relapse and dependence on glucocorticoids in giant cell arteritis. J Rheumatol 47(1):108–16. Available from: https://doi.org/10.3899/jrheum.181127
de Mornac D, Espitia O, Néel A, Connault J, Masseau A, Espitia-Thibault A et al (2021) Large-vessel involvement is predictive of multiple relapses in giant cell arteritis. Ther Adv Musculoskelet Dis 13:1759720X2110090. Available from: https://doi.org/10.1177/1759720x211009029
Sugihara T, Hasegawa H, Uchida HA, Yoshifuji H, Watanabe Y, Amiya E et al (2020) Associated factors of poor treatment outcomes in patients with giant cell arteritis: clinical implication of large vessel lesions. Arthritis Res Ther 22(1):72. Available from: https://doi.org/10.1186/s13075-020-02171-6
de Boysson H, Liozon E, Ly KH, Dumont A, Delmas C, Aouba A (2019) The different clinical patterns of giant cell arteritis. Clin Exp Rheumatol 37 Suppl 117(2):57–60
de Boysson H, Liozon E, Espitia O, Daumas A, Vautier M, Lambert M et al (2019) Different patterns and specific outcomes of large-vessel involvements in giant cell arteritis. J Autoimmun 103:102283. Available from: https://doi.org/10.1016/j.jaut.2019.05.011
Dejaco C, Ramiro S, Duftner C, Besson FL, Bley TA, Blockmans D et al (2018) EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice. Ann Rheum Dis 77(5):636–43. Available from: https://doi.org/10.1136/annrheumdis-2017-212649
Wa C, Seifert A, Gromnica-Ihle E (2008) Ultrasound of proximal upper extremity arteries to increase the diagnostic yield in large-vessel giant cell arteritis. Rheumatology 47:96–101
Muratore F, Kermani TA, Crowson CS, Green AB, Salvarani C, Matteson EL et al (2015) Large-vessel giant cell arteritis: a cohort study. Rheumatology (Oxford) 54(3):463–70. Available from: https://doi.org/10.1093/rheumatology/keu329
Brack A, Martinez-Taboada V, Stanson A, Goronzy JJ, Weyand CM (1999) Disease pattern in cranial and large-vessel giant cell arteritis. Arthritis Rheum 42(2):311–7. Available from: https://doi.org/10.1002/1529-0131(199902)42:2<311::AID-ANR14>3.0.CO;2-F
Ta K, Sreih AG (2019) Arterial lesions in giant cell arteritis: a longitudinal study. Semin Arthritis Rheum 48:707–713
Diamantopoulos AP, Haugeberg G, Hetland H, Soldal DM, Bie R, Myklebust G (2014) Diagnostic value of color Doppler ultrasonography of temporal arteries and large vessels in giant cell arteritis: a consecutive case series: US in GCA. Arthritis Care Res (Hoboken) 66(1):113–9. Available from: https://doi.org/10.1002/acr.22178
Karassa FB, Matsagas MI, Schmidt WA, Ioannidis JPA (2005) Meta-analysis: test performance of ultrasonography for giant-cell arteritis. Ann Intern Med 142(5):359–69. Available from: https://doi.org/10.7326/0003-4819-142-5-200503010-00011
Luqmani R, Lee E, Singh S, Gillett M, Schmidt WA, Bradburn M et al (2016) The Role of Ultrasound Compared to Biopsy of Temporal Arteries in the Diagnosis and Treatment of Giant Cell Arteritis (TABUL): a diagnostic accuracy and cost-effectiveness study. Health Technol Assess 20(90):1–238. Available from: https://doi.org/10.3310/hta20900
Arida A, Kyprianou M, Kanakis M, Sfikakis PP (2010) The diagnostic value of ultrasonography-derived edema of the temporal artery wall in giant cell arteritis: a second meta-analysis. BMC Musculoskelet Disord 11(1):44. Available from: https://doi.org/10.1186/1471-2474-11-44
EL Ball, SR Walsh, Tang TY, Gohil RC (2010) Role of ultrasonography in the diagnosis of temporal arteritis. Br J Surg 97:1765–1771. https://doi.org/10.1002/bjs.7252
Rinagel M, Chatelus E, Jousse-Joulin S, Sibilia J, Gottenberg J-E, Chasset F et al (2019) Diagnostic performance of temporal artery ultrasound for the diagnosis of giant cell arteritis: a systematic review and meta-analysis of the literature. Autoimmun Rev 18(1):56–61. Available from: https://doi.org/10.1016/j.autrev.2018.07.012
Sebastian A, Coath F, Innes S, Jackson J, van der Geest KSM, Dasgupta B (2021) Role of the halo sign in the assessment of giant cell arteritis: a systematic review and meta-analysis. Rheumatol Adv Pract 5(3):rkab059. Available from: https://doi.org/10.1093/rap/rkab059
Chrysidis S, Duftner C, Dejaco C, Schäfer VS, Ramiro S, Carrara G et al (2018) Definitions and reliability assessment of elementary ultrasound lesions in giant cell arteritis: a study from the OMERACT Large Vessel Vasculitis Ultrasound Working Group. RMD Open 4(1):e000598. Available from: https://doi.org/10.1136/rmdopen-2017-000598
Schäfer, V. S., Juche, A., Ramiro, S., Krause, A., & Schmidt, W. A. (2017). Ultrasound cut-off values for intima-media thickness of temporal, facial and axillary arteries in giant cell arteritis. Rheumatology (Oxford, England), 56(9), 1479–1483. https://doi.org/10.1093/rheumatology/kex143
De Miguel, E., Beltran, L. M., Monjo, I., Deodati, F., Schmidt, W. A., & Garcia-Puig, J. (2018). Atherosclerosis as a potential pitfall in the diagnosis of giant cell arteritis. Rheumatology (Oxford, England), 57(2), 318–321. https://doi.org/10.1093/rheumatology/kex381
Dasgupta, B., Smith, K., Khan, A., Coath, F., & Wakefield, R. J. (2019). 'Slope sign': a feature of large vessel vasculitis?. Annals of the rheumatic diseases, 78(12), 1738. https://doi.org/10.1136/annrheumdis-2019-216213
Mukhtyar C, Guillevin L, Cid MC, Dasgupta B, de Groot K, Gross W et al (2009) EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis [cited 2019 Sep 12];68(3):318–23. Available from: https://doi.org/10.1136/ard.2008.088351.
Sachdev, A., Dubey, S., George, M., Crossman, R., & Mehta, P. (2022). Role of Temporal artery biopsy in a sequential Giant Cell Arteritis fast-track pathway: a 5-year prospective study. Eye (London, England), 10.1038/s41433-022-02132-0. Advance online publication. https://doi.org/10.1038/s41433-022-02132-0
Duftner C, Dejaco C, Sepriano A, Falzon L, Schmidt WA, Ramiro S (2018) Imaging in diagnosis, outcome prediction and monitoring of large vessel vasculitis: a systematic literature review and meta-analysis informing the EULAR recommendations. RMD Open 4(1):e000612. Available from: https://doi.org/10.1136/rmdopen-2017-000612
Schäfer VS, Jin L, Schmidt WA (2020) Imaging for diagnosis, monitoring, and outcome prediction of large vessel vasculitides. Curr Rheumatol Rep 22(11):76. https://doi.org/10.1007/s11926-020-00955-y
Czihal M, Zanker S, Rademacher A, Tatò F, Kuhlencordt PJ, Schulze-Koops H et al (2012) Sonographic and clinical pattern of extracranial and cranial giant cell arteritis. Scand J Rheumatol [Internet] 41(3):231–236. Available from: https://doi.org/10.3109/03009742.2011.641581
Ghinoi A, Pipitone N, Nicolini A, Boiardi L, Silingardi M, Germanò G et al (2012) Large-vessel involvement in recent-onset giant cell arteritis: a case-control colour-Doppler sonography study. Rheumatology (Oxford) 51(4):730–734. Available from: https://doi.org/10.1093/rheumatology/ker329
Aschwanden M, Kesten F, Stern M, Thalhammer C, Walker UA, Tyndall A et al (2010) Vascular involvement in patients with giant cell arteritis determined by duplex sonography of 2x11 arterial regions. Ann Rheum Dis 69(7):1356–1359. Available from: https://doi.org/10.1136/ard.2009.122135
Nielsen BD, Hansen IT, Keller KK, Therkildsen P, Gormsen LC, Hauge E-M (2020) Diagnostic accuracy of ultrasound for detecting large-vessel giant cell arteritis using FDG PET/CT as the reference. Rheumatology (Oxford) [Internet] 59(8):2062–2073. Available from: https://doi.org/10.1093/rheumatology/kez568
Skoog J, Svensson C, Eriksson P, Sjöwall C, Zachrisson H (2021) The diagnostic performance of an extended ultrasound protocol in patients with clinically suspected giant cell arteritis. Front Med (Lausanne) [Internet] 8:807996. Disponible en: https://doi.org/10.3389/fmed.2021.807996
Molina Collada J, Martínez-Barrio J, Serrano-Benavente B, Castrejón I, Nieto-González JC, Caballero Motta LR et al (2021) Subclavian artery involvement in patients with giant cell arteritis: do we need a modified Halo Score? Clin Rheumatol [Internet] 40(7):2821–2827. Available from: https://doi.org/10.1007/s10067-020-05577-4
Aranda-Valera IC, García Carazo S, Monjo Henry I, De Miguel Mendieta E (2017) Diagnostic validity of Doppler ultrasound in giant cell arteritis. Clin Exp Rheumatol 35 Suppl 103(1):123–127
Lensen KD, Voskuyl AE, Comans EF, van der Laken CJ, Smulders YM (2016) Extracranial giant cell arteritis: a narrative review. Neth J Med 74(5):182–192
Acknowledgements
FERBT2022: The authors thank the Spanish Foundation of Rheumatology for providing medical writing/editorial assistance during the preparation of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
IMH: Speakers bureau: Roche, Novartis, UCB, Gedeon Richter; Consultant of: Roche. AB: Consultancies or speakers bureau: AbbVie, Pfizer, BMS, Nordic, Sanofi, Sandoz, Lilly, UCB, Roche, Galapagos, Gilead. EDM: Speakers bureau: AbbVie, Novartis, Pfizer, MSD, BMS, UCB, Roche, Grünenthal, Janssen, Sanofi; Paid instructor for: Janssen, Novartis, Roche; Consultant of: AbbVie, Novartis, Pfizer, Galapagos; Grant/research support from: AbbVie, Novartis, Pfizer. The other authors declare that they have no conflicts of interest.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Henry, I.M., Fernández Fernández, E., Peiteado, D. et al. Diagnostic validity of ultrasound including extra-cranial arteries in giant cell arteritis. Clin Rheumatol 42, 1163–1169 (2023). https://doi.org/10.1007/s10067-022-06420-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-022-06420-8